Keywords: HCC; HCA; hepatocellular adenoma; H&E; hematoxylin and eosin; HCC; hepatocellular carcinoma; HGDN; high-grade dysplastic nodule; seHCC; small and early HCC; spHCC; small and progressed HCC; DR; ductular reaction; MPF; medium-power field; GS; glutamine syntheta
مقالات ISI HCC (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCC; AFP; alpha fetoprotein; Akt; serine/threonrine kinase; ALT; alanine aminotransferase; apoAâ
; apolipoprotein Aâ
; AST; aspartate transaminase; CPT1; carnitine palmitoyltransferase 1; FASN; fatty acid synthase; GAPDH; glyceraldehyde-3-phosphate dehydroge
Keywords: HCC; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: HCC; Butein (PubChem CID: 5281222); Cardamonin (PubChem CID: 641785); 2â²,4â²-Dihydroxy-6â²-methoxy-3â²,5â²-dimethylchalcone (PubChem CID: 10424762); Flavokawain B (PubChem CID: 5356121); Hydroxysafflor Yellow A (PubChem CID: 6443665); Naringenin Chalcone
Keywords: HCC; Squalene epoxidase; Cancer treatment; Metabolism; Cell proliferation and migration; Cholesterol synthesis; SE; squalene epoxidase enzyme; SQLE; squalene epoxidase gene; CN; copy number; BC; breast cancer; HCC; hepatocellular carcinoma;
Keywords: HCC; Diagnostic Delay; Electronic Health Records; Health Information Technology; Medical Informatics; Primary Care; AFP; α-fetoprotein; CI; confidence interval; CRC; colorectal cancer; EHR; electronic health record; FIT; fecal immunochemical test; FOBT; fecal
Keywords: HCC; iFISH; Aneuploid CTC and circulating tumor stem cell; Hepatobiliary malignancy; Hepatocellular and cholangiocarcinoma; Surgical resection; HCC; hepatocellular carcinoma; CC; cholangiocarcinoma; CTC; circulating tumor cell; CTSC; circulating tumor stem cel
Keywords: HCC; Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: HCC; Local Regional Therapy; Liver Transplantation; Tumor Recurrence; Waitlist Dropout; AFP; alpha-fetoprotein; CI; confidence interval; CTP; Child-Turcotte-Pugh; HCC; hepatocellular carcinoma; HR; hazard ratio; IQR; interquartile range; LRT; local regional th
Keywords: HCC; DF; discriminant function; HCC; hepatocellular carcinoma; HPSS; Hopkins Psychosocial Scale; HRAR; High Risk Alcohol Relapse scale; IQR; interquartile range; MELD; Model for End-Stage Liver Disease; SAH; severe alcoholic hepatitis;
Keywords: HCC; Angiogenesis; HCC; EPC; Exosomes; Tumor microenvironment;
Keywords: HCC; Cancer; HCC; Immunotherapy;
Keywords: HCC; RNA Interference; Hepatic Carcinogenesis; Cell Cycle; Tumorigenesis; CCl4; carbon tetrachloride; DEN; diethylnitrosamine; dox; doxycycline; GalNAc; N-acetylgalactosamine; HCC; hepatocellular carcinoma; LNP; lipid nanoparticle; mRNA; messenger RNA; NTBC; n
Keywords: HCC; Adenoviral dodecahedron; Virus-like particle; Drug delivery, drug resistance, in vivo imaging; Ad Dd; adenoviral dodecahedron; Ad3; adenovirus type 3; BBB; blood-brain barrier; DOX; doxorubicin; FBS; fetal bovine serum; FSC; forward scatter; HCC; hepato
Keywords: HCC; Collateral Vessels; Portal Hypertension; Advanced Chronic Liver Disease; Portal Pressure; CI; confidence interval; CSPH; clinically significant portal hypertension; CT; computed tomography; EGD; esophagogastroduodenal; GI; gastrointestinal; HCC; hepatocel
Keywords: HCC; 5,10-CH2-THF; 5,10-methylene-tetrahydrofolate; CHX; cycloheximide; C; HCC tissues; DAPI; 4,6â²-diamidino-2-phenylindole; DCFH-DA; 2â²,7â²-Dichlorofluorescin diacetate; DMEM; Dulbecco's modified Eagle medium; ECL; enhanced chemiluminescence; EGF; epider
Keywords: HCC; AUC; area under the ROC curve; CCA; cholangiocarcinoma; EAC; esophageal adenocarcinoma; ESCC; Esophageal squamous cell carcinoma; FDA; US Food and Drug Administration; FIT; fecal immunochemical test; FOBT; fecal occult blood test; GI; gastrointestinal; HC
Keywords: HCC; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LR; liver resection; LT; liver transplantation; OS; overall survival;
Keywords: HCC; ACC; acetyl-CoA carboxylase; ASTX; astaxanthin; BAMBI; BMP and activin membrane-bound inhibitor homolog; BDL; bile duct ligation; CCL4; chemokine (C-C motif) ligand 4; CCR; chemokine receptor C-C motif; ChREBP; carbohydrate response element binding protei
Keywords: HCC; AASLD; American Association for the Study of Liver Diseases; AFP; alfa-fetoprotein; CART; classification and regression trees; cfDNA; circulating cell-free DNA; CTC; circulating tumor cells; ctDNA; circulating cell-free tumor DNA; CTscan; computed tomogra
Keywords: HCC; Combined Pinch and Exergy Analysis (CPEA); Exergoeconomic analysis; Heat Exchanger Networks; Advanced exergy analysis; South pars gas refinery; BHECC; balanced hot exergy composite curve; BCECC; balanced cold exergy composite curve; CAPEX; capital cost ex
Keywords: HCC; ERK; extracellular signal regulated kinase; FXR; farsenoid X receptor; HCC; hepatocellular carcinoma; HSCs; hepatic stellate cells; IL1β; Interleukin 1 beta; IL18; Interleukin 18; IKKβ; inhibitor of nuclear factor kappa-B kinase subunit beta; JAK; Janus
Keywords: HCC; ACC; acetyl-CoA carboxylase; ALDOA; aldolase A; AIs; aromatase inhibitors; AMPK; AMP-activated protein kinase; BC; breast cancer; CML; chronic myelogenous leukemia; CT; computed tomography; CPT1; carnitine palmitoyltransferase 1; CRC; colorectal cancer; 2
Keywords: HCC; ACC; acetyl CoA carboxylase; ACYL; ATP citrate lyase; Akt2; rac-β-serine-threonine kinase; ALA; α-linolenic acid; ALT; alanine aminotransferase; ARA; arachidonic acid, 20:4,Ï6; AST; aspartate aminotransferase; ATGL; adipocyte triglyceride lipase; CD36;
Keywords: HCC; Pul; pullulan; MRI; magnatic resonance imaging; PEI; polyethylenimine; SEM; scanning electron microscope; DLS; dynamic light scattering; SAXS; small angle X-ray scattering; FT-IR; Fourier-transform infrared spectroscopy; GPC; gel permeation chromatography
Keywords: HCC; Oxysterols; Cancer; Polymorphism; Risk; Genetics; Cholesterol; 25(OH)D; 25-hydroxyvitamin D; ABC; ATP-binding cassette; AEBS; antiestrogen-binding site; BC; breast cancer; BCR; biochemical recurrence; CETP; cholesteryl ester transfer protein; CH25H; chole
Keywords: HCC; BDTT; bile duct tumor thrombus; CT; computed tomography; ERCP; endoscopic retrograde cholangiopancreatography; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; MRI; magnetic resonance imaging; PVTT; portal vein tumor thrombus; Intrahep
Keywords: HCC; CT; computed tomography; HCC; hepatocellular carcinoma; POD; on postoperative day; DIC; drip infusion cholangiographic; Case report; Hepatocellular carcinoma; Hepatectomy; Postoperative bile leakage; Excluded bile leakage; Spiegel lobe;
Keywords: HCC; HCC; cancer vaccine; HEPAVAC; HLA-ligandome; HCC; hepatocellular carcinoma; ASR; age-standardized rate; HBV; hepatitis B virus; HCV; hepatitisC virus; TAAs; Tumor-associated antigens; DAMPs; damage-associated molecular patterns; DCs; dendritic cells; AFP;
Keywords: HCC; FOV; field of view; HASTE; half-Fourier acquisition single-shot turbo spin-echo; HCC; hepatocellular carcinoma; PVA; polyvinyl alcohol; TE; echo time; TR; repetition time; WHV; woodchuck hepatitis virus;
Keywords: HCC; HCC; hepatocellular carcinoma; LTP; local tumor progression; PEI; percutaneous ethanol injection; RF; radiofrequency;
Keywords: HCC; BRTO; balloon-occluded retrograde transvenous obliteration; CTP; Child-Turcotte-Pugh; HE; hepatic encephalopathy; HCC; hepatocellular carcinoma; MELD; model for end-stage liver disease; PARTO; plug-assisted retrograde transvenous obliteration; PSSs; p
Keywords: HCC; BPH; benign prostate hyperplasia; CRD; cysteine-rich domain; DKKs; Dickkopfs; DNMTs; DNA methyltransferases; Fz; Frizzled; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; LC; liver cirrhosis; LRP-5/6; low-density lipoprotein receptor-related protei
Keywords: HCC; HCC; hepatocellular carcinoma; BCLC; Barcelona-ClÃnic Liver Cancer; HAP; hepaticarterial phase; PVP; portal venous phase; ROC; receiver operating characteristic; AIC; akaike information criteria; OS; overall survival; DFS; disease free survival; TACE; tr
Keywords: HCC; TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: HCC; BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolics; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: HCC; AFB1; aflatoxin B1; CSC; cancer stem cell; ECM; extracellular matrix; EMT; epithelial-mesenchymal transition; ERK; extracellular signal-regulated kinase; GH; growth hormone; HCC; hepatocellular carcinoma; HIF-1; hypoxia-inducible factor-1; HK; hexokinase;
Keywords: HCC; HCC; hepatocellular carcinoma; LDLT; living-donor liver transplantation;
Keywords: HCC; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; TL; telomere length; MR; Mendelian randomization; GRS; genetic risk score; GWAS; Genome-wide association studies; MAF; minor allele frequency; HWE; Hardy-Weinberg equilibrium;
Keywords: HCC; Vascular occlusion; HCC; Long-term outcomes; Meta-analysis;
Keywords: HCC; AJCC; American Joint Committee on Cancer; HBH; high-burden hospital; HCC; hepatocellular carcinoma; LBH; low-burden hospital; MBH; medium-burden hospital; NCDB; National Cancer Database;
Keywords: HCC; Hepatocellular carcinoma; Personalized medicine; Sorafenib; Biomarkers; Molecular marker based-therapy; Individualized therapy; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; PCNA; proliferating cell nuclear antigen; CIN; chromosomal
Keywords: HCC; Hair cortisol concentration; Hair cortisol; HCC; Hair analysis; Long-term stress; Wash solvent; Wildlife; Bear;
Keywords: HCC; Ngb; neuroglobin; WHO; world health organization; NSCLC; non-small cell lung cancer; ER; estrogen receptor; HCC; hepatocellular carcinoma; MAPK; mitogen-activated protein kinase; NHA; normal human astrocyte; DMEM; Dulbecco minimum essential medium; FCS; f
Keywords: HCC; AFB1; aflatoxin B1; HCC; hepatocellular carcinoma; HCV; hepatitis C virus;
Keywords: HCC; prostatic neoplasms; biopsy; mass screening; Medicaid; African Americans; ASC; ambulatory surgical center; CMS; Centers for Medicare and Medicaid Services; HCC; Hierarchical Condition Category; mpMRI; multiparametric magnetic resonance imaging; PSA; prost
Keywords: HCC; AASLD; American Association for the Study of Liver Diseases; CECT; contrast enhanced computed tomography; CEMR; contrast enhanced magnetic resonance; CEUS; contrast enhanced ultrasound; CT; computed tomography; HCC; hepatocellular carcinoma; k; kappa valu
Keywords: HCC; HCC; hepatocellular carcinoma; SNPs; single nucleotide polymorphisms; HR; Hazard ratio; CI; Confidence interval;
Keywords: HCC; HCC; hepatocellular carcinoma; SNPs; single nucleotide polymorphisms; HR; hazard ratio; CI; confidence interval;
Keywords: HCC; CI; confidence interval; CLF; chronic liver failure; HCC; hepatocellular carcinoma; LT; liver transplant;